最新ニュース Carrier Global (NYSE:CARR) 株価情報

Carrier Global

Carrier Global manufactures heating, ventilation, and air conditioning, refrigeration, and fire and security products. The HVAC business serves both residential and commercial markets (HVAC segment sales mix is 60% commercial and 40% residential). Carrier's refrigeration segment consists of its transportation refrigeration, Sensitech supply chain monitoring, and commercial refrigeration businesses. The firm's fire and security business manufactures fire detection and suppression, access controls, and intrusion detection products. In April 2023, Carrier announced that it plans to divest its fire and security and commercial refrigeration businesses. The firm also acquired Germany-based Viessmann for approximately $13 billion.

Carrier Global Corp

CARRY WEALTH HLDGS LTD by Carry Wealth Holdings Ltd.

Carrefour

CARRIAGE HOUSE EVENT CTR by Carriage House Event Center Inc.

Carriage House Event Center Inc

Carriage Services Inc

CARRIER ALLIANCE HLDGS by Carrier Alliance Holdings, Inc.

Carrier Alliance Holdings Inc

CAROLL SHELBY INTL INC by Carroll Shelby International, Inc.

Carroll Shelby International Inc

Carrols Restaurant Group Inc Com

Carry

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) owners have been subject to <a href="https://www.benzinga.com/markets/equities/25/03/44474423/fbi-launches-task-force-to-address-tesla-protests-director-kash-patel-condemns-violence-as-domes">increased reports of vandalism</a> and targeted attacks as the electric vehicle company faces declining brand value in the wake of CEO Elon Musk's continued political push.
Those same owners could be in for another challenge in 2025: increased insurance payments.
What Happened: Increased vandalism on Tesla vehicles and<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44380301/tesla-analyst-says-demand-fears-overblown-but-has-some-concerns-as-used-car-prices-plummet"> lower used car values </a>are among the negatives facing Tesla owners in 2025 after Musk's push in politics has angered many and hurt the brand value of the EV giant.
A new report from <a href="https://insurify.com/car-insurance/insights/car-models-highest-insurance-increase/">Insurify</a>, shared by <a href="https://electrek.co/2025/04/14/tesla-insurance-premiums-are-incresing-at-twice-market-rate-amid-vandalism/">Electrek</a>, shows that higher insurance premiums could be another negative for Tesla owners in 2025 and things could get worse.
Overall automotive insurance premiums have risen due to a fear that tariffs that could make auto repair costs and replacement costs more expensive. The average cost of full coverage on a vehicle is up 10% year-over-year to $2,302, the report found.
Among the vehicles with the largest increase are several Tesla models. Here's a look at the top 10 vehicles seeing the largest increase in premiums from 2024 to 2025 in the U.S.:
<ol>
<li>Tesla Model Y: +29%, $3,996 average annual cost</li>
<li>Tesla Model 3: +24%, $4,364 average annual cost</li>
<li>Tesla Model X: +22%, $4,046 average annual cost</li>
<li>BMW 5 Series: +19%, $3,229 average annual cost</li>
<li>Toyota Prius: +18%, $2,151 average annual cost</li>
<li>Hyundai Santa Fe: +15%, $2,241 average annual cost</li>
<li>Honda Accord: +14%, $2,623 average annual cost</li>
<li>Hyundai Elantra: +14%, $2,851 average annual cost</li>
<li>Honda Civic: +13%, $2,600 average annual cost</li>
<li>Hyundai Sonata: +12%, $2,735 average annual cost</li>
</ol>
Tesla has the top three brands that have seen the largest year-over-year increase from 2024 to 2025 in the United States according to the report.
Read Also: <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">EXCLUSIVE: Tesla Protest Organizer Says &#8216;Elon Musk Seems To Have Purchased The American Government&#8217;</a>
Why It's Important: The survey was done between February 2024 and February 2025, which means that insurance rates could actually be even higher with vandalism on Tesla vehicles high in recent months.
Tesla parts have been known to be expensive to repair, often leading to large premiums from insurance companies to offset the potential cost.
Tesla has its own insurance segment, but it is not available in all states.
The higher insurance costs and worries about tariffs could scare consumers away from electric vehicles in 2025, especially Tesla vehicles. While consumers can save money at the pump with an EV, owners are now faced with the decisions of lower resale value than past years and higher insurance rates for Tesla vehicles.
TSLA Price Action: Tesla stock was up 0.7% to $254.11 on Tuesday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is down 33% year-to-date in 2025.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44802015/us-electric-vehicle-sales-up-11-in-q1-as-tesla-declines-the-winners-and-losers">Tesla Loses Steam In Q1 While US EV Sales Climb: The Winners And Losers</a></li>
</ul>
Photo: Shutterstock

Trading Ideas

Insurance

TSLA

Tesla Owners Face New Challenge Amid Tariffs, Vandalism: Insurance Costs Going Up Twice The National Rate

Watsco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSO#NYSE">WSO</a>) has outperformed the market over the past 5 years by 14.32% on an annualized basis producing an average annual return of 28.13%. Currently, Watsco has a market capitalization of $20.61 billion. 
Buying $1000 In WSO: If an investor had bought $1000 of WSO stock 5 years ago, it would be worth $3,308.44 today based on a price of $510.36 for WSO at the time of writing.
<h3>Watsco's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744757110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

The <a href="https://www.benzinga.com/general/entertainment/24/01/36476388/from-mario-to-minecraft-jack-black-boards-new-video-game-adaptation">highly anticipated "Minecraft" movie </a>has turned into a blockbuster hit for Warner Bros. Discovery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) and could be a revenue generator for theater companies like AMC Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) and Cinemark Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>).
The impressive box office numbers will also likely mean more video games getting adapted into movies and TV series as media companies look for built-in fan bases.
What Happened: Billionaire Elon Musk is well-known for many things, including <a href="https://www.benzinga.com/general/gaming/23/08/33610477/elon-musk-lover-of-video-games-has-praise-for-this-record-breaking-title-and-its-not-elden-ring">his love of video games</a> such as "Diablo 4" and "Elden Ring."
With the success of "Minecraft" at the box office, Musk is now hoping for one of those hit games to be made into a movie.
Musk responded to former Blizzard Entertainment executive Mark Kern, also known as Grummz, who shared a post from GamesIndustry suggesting more video game adaptations are likely coming.
"Just like comics were in the past, the rich history of video games is now the wellspring of creative storytelling," Musk <a href="https://x.com/elonmusk/status/1911978724905431227">tweeted</a>.
One X user suggested that they should make a movie based on "Elden Ring" next.
"That would be awesome," Musk <a href="https://x.com/elonmusk/status/1911979256730570887">replied</a>.
Musk has often shared his love of the 2022 video game developed by FromSoftware that counts Japanese game developer Hidetaka Miyazaki and "Game of Thrones" author George R.R. Martin as figures who worked on the development of the action role-playing game.
"Minecraft" <a href="https://www.boxofficemojo.com/release/rl746096129/?ref_=bo_hm_rd">opened </a>with $162.8 million domestically and has now grossed $278.9 million domestically and $552.7 million worldwide. The film is the top-grossing film domestically in 2025 beating "Captain America: Brave New World" and is the second-highest-grossing film worldwide for the year.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
What's Next: The success of "Minecraft" could lead to more video games being made into movies and shows. "Minecraft" was released in 2011 and the game's parent Mojang was later acquired by Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) for $2.5 billion in 2014.
The film came with a built-in fan base of varying ages, which could explain how it beat original estimates of $70 to $90 million for its domestic opening. As movie studios and streamers look for their next hits, games with built-in fan bases could be attractive.
"Minecraft itself is a cultural juggernaut — over 300 million copies sold, and a fanbase spanning kids to adults who've been building pixelated empires for years," Exhibitor Relations box office analyst Jeff Bock told <a href="https://www.gamesindustry.biz/video-games-franchises-are-now-ripe-for-the-picking-why-a-minecraft-movie-could-lead-to-games-taking-over-hollywood">GamesIndustry</a>.
Alinea Analytics Head of Market Analysis Rhys Elliott highlighted the timing of the film not being around other blockbusters and coming at a time when many schools were on spring break as a potential win by Warner Bros. marketing team.
Elliott said recent hits like "The Super Mario Bros. Movie" and the Sonic film franchise have shown how video game adaptations can be successful.
&#8220;The Mario movie even outperformed juggernauts like Frozen and Despicable Me. If studios weren't paying attention to games before, they certainly were after Mario. And now Minecraft is another feather in that cap," Elliott said. &nbsp;
While more announcements could be made, there are already many video games in the works of being adapted into films or shows, including "Death Stranding," which was announced as a new A24 movie after "Minecraft's" opening.
Up next for game adaptations is the April 25, 2025, release of the "Until Dawn" movie from Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>), as reported by <a href="https://www.ign.com/articles/upcoming-video-game-movies-and-tv-shows">IGN</a>. There are also sequels to "Mortal Kombat" and "Five Nights at Freddy's" scheduled for this year. In 2026, movies include "Street Fighter," and "The Super Mario Bros. Movie 2."
On the television side, "The Last of Us" has been a successful video game adaptation to TV for Warner Bros. Discovery with a second season recently premiering on HBO and Max. "Fallout" has also been a hit for Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), with a second season in the works and the first season leading to strong sales for the video game franchise.  
The success of the &#8220;Minecraft&#8221; movie could also be a positive for Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), which is working on<a href="https://www.benzinga.com/general/entertainment/24/05/39096394/minecraft-series-coming-to-major-streaming-platform-microsofts-hit-game-thrives"> a series adaptation </a>of the hit game.
While many video game adaptations have been hits, not all of them work out. The 2024 "Borderlands" film grossed less than $20 million domestically and grossed $33 million worldwide.
Speculation about the hit Epic Games "Fortnite" battle royale game being turned into a movie was quickly downplayed by Epic Games CEO Tim Sweeney, as <a href="https://comicbookmovie.com/video-games/epic-games-ceo-refutes-rumors-of-fortnite-movie-following-a-minecraft-movie-success-a218548">reported </a>by ComicBookMovie.com. Sweeney tweeted "false" to a fan's post that "Fortnite" would be the next game adapted for the big screen and that some studios had already passed on the film rights. Sweeney did not clarify which part or, if both, were false.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/21/12/24634416/minecraft-hits-1-trillion-views-on-youtube-how-the-game-has-maintained-its-user-base">Minecraft Hits 1 Trillion Views On YouTube: How The Game Has Maintained Its User Base</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/alexphotostock">Alex Photo Stock</a> via Shutterstock

Entertainment

Gaming

AMZN

MSFT

NFLX

Sony Group Corporation American Depositary Shares

SONY

'Minecraft' Box Office Success Could See More Adaptations: Elon Musk Wants This Video Game Movie Next

If you ask OpenAI, Elon Musk didn't just walk away from the company he helped build — he lit the match and now wants to watch it burn.
In a scorching new legal filing, <a href="https://www.benzinga.com/25/04/44726544/elon-musk-faces-legal-backlash-as-sam-altman-led-openai-countersues-over-harassing-tactics-and-bid-for-control-musk-has-tried-every-tool-available-to-harm-openai">OpenAI fired back at Musk's ongoing lawsuit</a> with a detailed and unfiltered version of events — accusing him of abandoning the company, declaring it dead on arrival, and later launching a campaign to destroy it when it refused to hand him the reins.
"Musk could not tolerate seeing such success for an enterprise he had abandoned and declared doomed," OpenAI's legal team wrote in a <a href="https://www.documentcloud.org/documents/25893390-20250409-openai-defendants-counterclaims-answer-and-defenses/">Wednesday court filing</a>. "He made it his project to take down OpenAI, and to build a direct competitor that would seize the technological lead — not for humanity but for Elon Musk."
Don't Miss:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.</li>
<li><a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a></li>
</ul>
The filing claims Musk weaponized everything in his arsenal — from his massive social media following to legal threats — to kneecap the company once it became clear he couldn't control it.
"The ensuing campaign has been relentless," the filing added. "Through press attacks, malicious campaigns broadcast to Musk's more than 200 million followers on the social media platform he controls, a pretextual demand for corporate records, harassing legal claims, and a sham <a href="https://www.benzinga.com/25/02/43609104/elon-musk-co-founded-openai-now-hes-bidding-974b-to-take-back-the-company">bid for OpenAI's assets</a>, Musk has tried every tool available to harm OpenAI."
The legal battle began when Musk sued OpenAI in February 2024, alleging the company had strayed from its original nonprofit mission and formed a for-profit structure that favors Microsoft. Musk dropped the suit in June — only to refile it in August. On Wednesday, the judge scheduled a trial for next March.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
But OpenAI isn't just playing defense. On the same day as the filing, the company posted a series of <a href="https://x.com/OpenAINewsroom/status/1910105151492575611">sharp jabs at Musk on X</a>.&nbsp;
"Elon's nonstop actions against us are just bad-faith tactics to slow down OpenAI and seize control of the leading AI innovations for his personal benefit," the company posted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon's nonstop actions against us are just bad-faith tactics to slow down OpenAI and seize control of the leading AI innovations for his personal benefit. Today, we counter-sued to stop him.
&mdash; OpenAI Newsroom (@OpenAINewsroom) <a href="https://twitter.com/OpenAINewsroom/status/1910105151492575611?ref_src=twsrc%5Etfw">April 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
"Elon's never been about the mission. He's always had his own agenda. He tried to seize control of OpenAI and merge it with Tesla as a for-profit — his own emails prove it. When he didn't get his way, he stormed off."
The post continued, "Elon is undoubtedly one of the greatest entrepreneurs of our time. But these antics are just history on repeat – Elon being all about Elon."
Musk's Early Role — and Abrupt Exit
Musk co-founded OpenAI in 2015 alongside Sam Altman and others, helping launch the nonprofit with a vision of building artificial intelligence that benefits all of humanity. He pledged $1 billion in support, though OpenAI later said he <a href="https://openai.com/index/openai-elon-musk/">only contributed a fraction of that</a> before stepping away.
Trending: <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">With Shares Starting at Just $1.52, This Could be Your Chance to Invest in the Future of Healthcare.</a>
By 2018, tensions were rising. Musk reportedly proposed taking over the company and folding it into Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) — a move that other board members rejected. Musk left the board shortly after.
At the time, Musk publicly said he walked away to avoid a conflict of interest with Tesla's own AI work and because he "didn't agree with some of what the OpenAI team wanted to do." He didn't elaborate on what those differences were, but former employees have hinted that the disagreements ran deep.
Altman, for his part, has rarely spoken publicly about the split — until now.
Wednesday's court filing paints Musk as someone who believed OpenAI was doomed without his leadership. But when the company went on to create the most widely-used AI product in history — ChatGPT — it says Musk couldn't stand being left behind.
Now, Musk is backing xAI, his own AI startup launched in 2023, which he claims will build a safer, more transparent artificial intelligence model. Its first product, Grok, is integrated into X.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
The Bigger Battle Over AI's Future
While the courtroom fireworks keep flying, this fight goes beyond just bruised egos. At the heart of Musk's lawsuit is a claim that OpenAI's for-profit pivot violates the company's founding agreement and undermines its mission to serve humanity.
But OpenAI insists that Musk knew about — and even supported — the pivot, right up until he didn't get his way.
Now, OpenAI is asking the court to toss Musk's claims entirely.
With a trial date set, the world's biggest names in AI look <a href="https://www.benzinga.com/tech/25/03/44066117/elon-musk-battles-openai-over-move-to-for-profit-model-and-experts-are-pushing-back">ready for a long, ugly fight</a> — one that could shape the future of artificial intelligence, and who gets to control it.
Read Next:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Personal Finance

'Musk Could Not Tolerate Seeing Such Success' — OpenAI Says He Abandoned And Declared Them 'Doomed,' Then Tried to Destroy It All

Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) has outperformed the market over the past 10 years by 11.16% on an annualized basis producing an average annual return of 21.03%. Currently, Palo Alto Networks has a market capitalization of $113.78 billion. 
Buying $1000 In PANW: If an investor had bought $1000 of PANW stock 10 years ago, it would be worth $7,107.36 today based on a price of $171.85 for PANW at the time of writing.
<h3>Palo Alto Networks's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744756212_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PANW

Here's How Much $1000 Invested In Palo Alto Networks 10 Years Ago Would Be Worth Today

Despite renewed fears that President Donald Trump's proposed tariffs could reignite inflation, an emerging contrarian theory suggests the reality may be far less alarming than many on <a href="https://www.benzinga.com/topic/inflation">Wall Street currently expect.</a>
In a note shared Tuesday, Yardeni Research President Ed Yardeni said investors and consumers might be overstating the inflationary consequences of what he dubbed Trump's "Nitro Tariffs," or TNT.
"Tariffs are stagflationary," Yardeni said, "but consensus expectations may be overestimating the inflationary impact and underestimating the downside risks to growth."
<h1 class="wp-block-heading">Are Tariff Inflation Fears Justified?</h1>
Latest consumer sentiment data is painting a confusing picture. The Federal Reserve Bank of New York reported consumer expectations for inflation rose to 3.6% in March.
That number is well below the University of Michigan's Consumer Sentiment Index, which showed a jump in inflation expectations to 5% during the same month. In April, the latter soared again to 6.7%.
The veteran Wall Street analyst called the University of Michigan's reading "too panicky," pointing to historical data that ties the survey's inflation expectations closely to gasoline prices, which have remained subdued. 
"Inflation might not rise as much as feared," he said.
That divergence has created a narrative of anxiety that, according to Yardeni, might not align with market data. 
"The recent divergence clearly reflects consumers' fears that tariffs will boost inflation," he said, but the correlation with pump prices doesn't support the uptick in panic.
To see inflation truly spike to levels feared by some consumers, Yardeni argued, a major oil price shock would likely be required. But oil prices are moving in the opposite direction, pressured by fears of slowing global growth. 
A barrel of crude is now trading lower than it was earlier this year — a disinflationary tailwind that may continue to offset the effects of tariffs.
Crude prices as tracked by the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) have fallen by nearly 15% since Trump&#8217;s reciprocal tariff announcement on April 2. Futures tracking gasoline contracts have dropped from $2.30 to $2 a gallon. 
<h1 class="wp-block-heading">Bond Market&#8217;s Inflation Gauges Stay Calm</h1>
Bond markets, usually quick to react to inflation jitters, are notably unshaken. 
The yield spread between 10-year nominal Treasury bonds and inflation-protected securities (TIPS), a common measure of inflation expectations, has drifted lower. 
Inflation swaps for the 5-to-10-year horizon — a preferred gauge of future expectations — have also hovered near the Federal Reserve's 2.0% target, as Yardeni noted. 
<h1 class="wp-block-heading">Goods Deflation Could Persist</h1>
The past two years have seen a sharp cooling in goods prices, a trend driven by post-COVID-19 pandemic demand normalization and oversupply from China. Yardeni suggested this disinflationary trend could continue, even in the face of new tariffs.
"Over the medium term, Trump's Nitro Tariffs might not upset these patterns," he said. "Goods prices might continue to deflate."
One key reason: China's likely evasion of tariffs by rerouting exports through third-party countries. With its economy under pressure, China has a strong incentive to keep goods flowing, tariff walls or not.
<h1 class="wp-block-heading">Growth, Not Inflation, Is the Real Risk</h1>
While the inflation narrative dominates headlines, Yardeni's contrarian view is that the more serious danger lies in weaker economic activity. 
&#8220;In our view, the bigger risk is to growth. The volatility of TNT has cast so much uncertainty over both businesses and consumers that spending, hiring and investment are likely to sharply slow over the next few months,&#8221; he stated.
Add in potential trade retaliation from foreign partners, and the growth outlook gets cloudier still.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/44824856/retail-traders-rush-into-leveraged-tech-etfs-betting-on-nasdaq-rebound-after-sharp-drop">Retail Traders Rush Into Leveraged Tech ETFs, Betting On Nasdaq Rebound After Sharp Drop</a></li>
</ul>
Photo: Shutterstock

Government

Macro Economic Events

Regulations

Bonds

Specialty ETFs

Econ #s

Economics

ETFs

Trump Tariffs May Not Ignite Inflation After All, Says Yardeni

JP Morgan analyst Harlan Sur reiterated an Underweight rating on Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) on Tuesday, setting a <a target="_blank" href="https://www.benzinga.com/quote/INTC/analyst-ratings" rel="noreferrer noopener">price forecast of $23</a>.
On Monday, before the market opened, Intel announced a <a target="_blank" href="https://www.benzinga.com/25/04/44792707/intel-stock-surges-5-on-potential-altera-sale-trumps-tariff-relief-provides-added-boost" rel="noreferrer noopener">51% stake sale</a> of its programmable chip business, Altera, to private equity firm Silver Lake Management for $4.46 billion, valuing Altera at $8.75 billion with a transaction multiple of ~5.7 times calendar 2024 sales.
As a reference, Intel bought Altera in 2015 at 9 times calendar 2014 sales and in 2020, and Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) bought Xilinx for 11 times calendar 2019 sales).
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44786708/why-are-semiconductor-stocks-trading-higher-on-monday" rel="noreferrer noopener">Chip Stocks Rise as Trump Pushes Tariffs, Exempts Phones and Backs US Semiconductor Production</a>
Over the past 10 years, since Intel acquired Altera, revenues have declined by 20% compared to 87% growth for the overall semiconductor industry.
The transaction marks Intel&#8217;s first significant strategic move under its new CEO, Lip-Bu Tan. It underpins the company&#8217;s broader turnaround strategy and refocuses on its core x86 businesses.&nbsp;&nbsp;
Financially, Altera generated $1.54 billion in revenue last year (putting the deal value at 6 times calendar 2024 sales) with ~50% adjusted gross margin, and we estimate Altera&#8217;s revenue to grow to $1.6 billion (+4%) in calendar 2025.
Intel originally acquired Altera for $16.7 billion in December 2015, 9 times calendar 2014 sales. The lower transaction value reflects a lower revenue profile (Altera revenues are down 20% over the past 10 years versus 87% growth in the semiconductor industry) and margin profile.
Intel plans to de-consolidate Altera from its financial statements and expects to close the deal in the second half of calendar 2025.&nbsp;The sale strengthens Intel&#8217;s balance sheet amid a more challenging macro environment.
Raghib Hussain will succeed Sandra Rivera as CEO of Altera (effective May 5). Previously, Raghib was President of Products and Technologies at Marvell Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), overseeing advancements in its custom AI chips and networking solutions business.
Raghib led the Data Center Cloud Group, focusing on integrated silicon portfolios for switching, connectivity, and computing.
Overall, Sur noted this is a step in the right direction. However, he remained underweight on the stock as Intel continues to navigate through a challenging period, as it right-sizes the company and continues to move forward with its technology/manufacturing product roadmaps.
Sur projected first-quarter revenue of $12.2 billion and adjusted EPS of $0.00.
Price Action: INTC stock closed lower by 2.26% at $19.85 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44819954/apple-plans-on-device-ai-data-analysis-to-boost-privacy-catch-up-in-ai-race" target="_blank" rel="noreferrer noopener">Apple Plans On-Device AI Data Analysis To Boost Privacy, Catch Up In AI Race</a></li>
</ul>
Photo Courtesy: Tada Images On Shutterstock

Price Target

Reiteration

Analyst Ratings

Movers

Tech

INTC

MRVL

Intel Growth Challenges Are Not Over Despite Altera Stake Sale: Analyst

Chemed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) has outperformed the market over the past 15 years by 6.62% on an annualized basis producing an average annual return of 17.1%. Currently, Chemed has a market capitalization of $8.62 billion. 
Buying $1000 In CHE: If an investor had bought $1000 of CHE stock 15 years ago, it would be worth $10,410.08 today based on a price of $588.69 for CHE at the time of writing.
<h3>Chemed's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744755323_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Chemed 15 Years Ago Would Be Worth Today

General

THTX

Theratechnologies Provides Update on Sale Process; Says The Board Of Directors Of The Company Has Decided To Further Evaluate The Potential Sale Of The Company Through An Open And Non-Exclusive Process

NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares are moving lower in Tuesday&#8217;s after-hours session after the company said it was recently informed by the U.S. government that it will need a license to <a href="https://www.benzinga.com/25/04/44770461/intel-on-slump-as-china-hits-us-made-chips-with-tariffs-amd-and-taiwan-semiconductor-rise-on-exemption-boost">export chips to China</a>.
What To Know: After market close on Tuesday, Nvidia said in a regulatory filing that the U.S. government contacted the company on April 9 to let it know it will need a license to sell H20 chips to China.
A license will also be required for any other circuits achieving the H20's memory bandwidth, interconnect bandwidth, or a combination thereof, Nvidia said in the filing.
Trending:
<ul>
<li>Inspired by Uber and Airbnb&#8230; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets — <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
<ul>
<li>With high-demand properties in the Midwest, Bam Capital has delivered 2.46x equity multiples in just over 3 years. No losses. No missed payments. <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">Learn more about becoming an investor today</a>. </li>
</ul>
The U.S. government told Nvidia that the new license requirement addresses risks associated with the potential for China to use the products for a supercomputer. The license requirement will be in effect for the indefinite future.
As a result of the restrictions, Nvidia said it expects its first-quarter financial results to include up to $5.5 billion of charges associated with H20 products held in inventory, purchase commitments and related reserves. The company&#8217;s first quarter of fiscal 2026 is set to end on April 27, 2025.
The license requirement appears to be the latest in an intensifying <a href="https://www.benzinga.com/markets/25/04/44806095/as-xi-jinping-urges-vietnam-to-stand-against-unilateral-bullying-trump-labels-the-meeting-a-plan-to-screw-the-united-states-of-america">trade war with China</a>. President Donald Trump paused reciprocal tariffs for most countries last week, but ramped up tariffs on China. China slapped 125% retaliatory tariffs on American goods over the weekend. 
NVDA Price Action: <a href="http://benzinga.com/quote/nvda">Nvidia shares</a> were down 6.33% after hours, trading at $105.10 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a> </li>
<li>This well known prop trading firm is offering 100% of your first $25,000 profit per account and 90% after that. <a href="https://www.benzinga.com/money/apex-trader-funding">Here's how to get a special 50% OFF CODE that lets you start out with monthly investments as low as $147 today.</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Hepha1st0s">Hepha1st0s</a>/Shutterstock.

Global

After-Hours Center

NVDA

Nvidia Stock Is Tumbling After Hours: Here's Why

Throughout the last three months, 4 analysts have evaluated Tenaris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TS#NYSE">TS</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $46.0, along with a high estimate of $50.00 and a low estimate of $41.00. Observing a 2.79% increase, the current average has risen from the previous average price target of $44.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754478_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Tenaris among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Stephen Gengaro &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $41.00&#x7C;$43.00 &#x7C; 
&#x7C;Derek Podhaizer &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $50.00&#x7C;$48.00 &#x7C; 
&#x7C;David Anderson &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $50.00&#x7C;$48.00 &#x7C; 
&#x7C;Stephen Gengaro &#x7C;Stifel &#x7C;Raises &#x7C;Buy &#x7C; $43.00&#x7C;$40.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Tenaris. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tenaris compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Tenaris's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Tenaris's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Tenaris analyst ratings.</a>
<h2>About Tenaris</h2>
Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the US, Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.
<h3>Tenaris: Financial Performance Dissected</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Tenaris's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -16.68%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Tenaris's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 18.14%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Tenaris's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.06%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Tenaris's ROA stands out, surpassing industry averages. With an impressive ROA of 2.48%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.04.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Have This To Say About Tenaris

In the latest quarter, 9 analysts provided ratings for Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $225.56, a high estimate of $260.00, and a low estimate of $190.00. This current average represents a 5.4% decrease from the previous average price target of $238.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754465_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Inspire Medical Systems. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Shagun Singh &#x7C;RBC Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $215.00&#x7C;$260.00 &#x7C; 
&#x7C;Richard Newitter &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $235.00&#x7C;$250.00 &#x7C; 
&#x7C;Shagun Singh &#x7C;RBC Capital &#x7C;Maintains &#x7C;Outperform &#x7C; $260.00&#x7C;$260.00 &#x7C; 
&#x7C;Mike Polark &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $248.00&#x7C;$252.00 &#x7C; 
&#x7C;Larry Biegelsen &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $195.00&#x7C;$198.00 &#x7C; 
&#x7C;Kallum Titchmarsh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $220.00&#x7C;$230.00 &#x7C; 
&#x7C;Adam Maeder &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $233.00&#x7C;$260.00 &#x7C; 
&#x7C;Brett Fishbin &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $234.00&#x7C;$236.00 &#x7C; 
&#x7C;Jonathan Block &#x7C;Stifel &#x7C;Lowers &#x7C;Hold &#x7C; $190.00&#x7C;$200.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Inspire Medical Systems. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Inspire Medical Systems compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Inspire Medical Systems's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Inspire Medical Systems's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/INSP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Inspire Medical Systems analyst ratings.</a>
<h2>Unveiling the Story Behind Inspire Medical Systems</h2>
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
<h3>Inspire Medical Systems: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Inspire Medical Systems's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 24.52%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Inspire Medical Systems's net margin is impressive, surpassing industry averages. With a net margin of 14.69%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Inspire Medical Systems's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.08% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Inspire Medical Systems's ROA stands out, surpassing industry averages. With an impressive ROA of 4.39%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INSP

What Analysts Are Saying About Inspire Medical Systems Stock

4 analysts have expressed a variety of opinions on Strategic Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRA#NASDAQ">STRA</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $118.0, with a high estimate of $135.00 and a low estimate of $97.00. Highlighting a 6.35% decrease, the current average has fallen from the previous average price target of $126.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754455_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Strategic Education's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Alexander Paris &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $120.00&#x7C;$120.00 &#x7C; 
&#x7C;Jeffrey Silber &#x7C;BMO Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $97.00&#x7C;$114.00 &#x7C; 
&#x7C;Alexander Paris &#x7C;Barrington Research &#x7C;Lowers &#x7C;Outperform &#x7C; $120.00&#x7C;$135.00 &#x7C; 
&#x7C;Alexander Paris &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $135.00&#x7C;$135.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Strategic Education. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Strategic Education compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Strategic Education's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Strategic Education's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/STRA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Strategic Education analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Strategic Education Better</h2>
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.
<h3>Understanding the Numbers: Strategic Education's Finances</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Strategic Education's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.89% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Strategic Education's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 8.13%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Strategic Education's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.5%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Strategic Education's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.2%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.08.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

STRA

Strategic Education Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Across the recent three months, 6 analysts have shared their insights on Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $37.33, a high estimate of $51.00, and a low estimate of $26.00. A 23.03% drop is evident in the current average compared to the previous average price target of $48.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754445_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Alcoa by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Curt Woodworth &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $32.00&#x7C;$47.00 &#x7C; 
&#x7C;Bill Peterson &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $28.00&#x7C;$40.00 &#x7C; 
&#x7C;Lawson Winder &#x7C;B of A Securities &#x7C;Lowers &#x7C;Underperform &#x7C; $26.00&#x7C;$58.00 &#x7C; 
&#x7C;Curt Woodworth &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $47.00&#x7C;$53.00 &#x7C; 
&#x7C;Carlos De Alba &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $51.00&#x7C;$55.00 &#x7C; 
&#x7C;Bill Peterson &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $40.00&#x7C;$38.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Alcoa. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Alcoa compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Alcoa's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Alcoa analyst ratings.</a>
<h2>Discovering Alcoa: A Closer Look</h2>
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.
<h3>Alcoa's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Alcoa's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 34.34%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 5.79%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.88%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Alcoa's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.41%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Alcoa's debt-to-equity ratio surpasses industry norms, standing at 0.55. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Alcoa Stands With Analysts

In the last three months, 4 analysts have published ratings on Omnicom Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $108.25, a high estimate of $116.00, and a low estimate of $103.00. Experiencing a 9.03% decline, the current average is now lower than the previous average price target of $119.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754436_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Omnicom Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Jason Bazinet &#x7C;Citigroup &#x7C;Announces &#x7C;Buy &#x7C; $103.00&#x7C;- &#x7C; 
&#x7C;Adam Berlin &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $104.00&#x7C;$117.00 &#x7C; 
&#x7C;David Karnovsky &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $116.00&#x7C;$119.00 &#x7C; 
&#x7C;Julien Roch &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $110.00&#x7C;$121.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Omnicom Group. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Omnicom Group compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Omnicom Group's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Omnicom Group's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/OMC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Omnicom Group analyst ratings.</a>
<h2>Get to Know Omnicom Group Better</h2>
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, and ad placement. In addition, Omnicom provides outsourced public relations and other communications services. The firm operates globally, providing services in more than 70 countries; it generates more than half of its revenue in North America and nearly 30% in Europe. The firm announced plans to merge with Interpublic Group in December 2024, pending regulatory approval.
<h3>Unraveling the Financial Story of Omnicom Group</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining Omnicom Group's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.43% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Communication Services sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Omnicom Group's net margin excels beyond industry benchmarks, reaching 10.37%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Omnicom Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.0% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Omnicom Group's ROA excels beyond industry benchmarks, reaching 1.53%. This signifies efficient management of assets and strong financial health.
Debt Management: Omnicom Group's debt-to-equity ratio stands notably higher than the industry average, reaching 1.64. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Omnicom Group Through 4 Analysts

In the current market session, Analog Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) price is at $179.54, after a 0.53% spike. However, over the past month, the stock decreased by 14.16%, and in the past year, by 5.22%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1744754420_0.png" alt="Past Year Chart" />

<h3>How Does Analog Devices P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Analog Devices has a lower P/E than the aggregate P/E of 111.96 of the Semiconductors &amp; Semiconductor Equipment industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744754420_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Analog Devices

Throughout the last three months, 9 analysts have evaluated Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $17.78, along with a high estimate of $22.00 and a low estimate of $13.00. A 15.77% drop is evident in the current average compared to the previous average price target of $21.11. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754420_0_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Huntsman. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Neutral &#x7C; $15.00&#x7C;$22.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $17.00&#x7C;$20.00 &#x7C; 
&#x7C;Joshua Spector &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $13.00&#x7C;$18.00 &#x7C; 
&#x7C;Patrick Cunningham &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $14.00&#x7C;$19.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $20.00&#x7C;$22.00 &#x7C; 
&#x7C;Duffy Fischer &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Sell &#x7C; $19.00&#x7C;$22.00 &#x7C; 
&#x7C;Arun Viswanathan &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $18.00&#x7C;$17.00 &#x7C; 
&#x7C;Jeffrey Zekauskas &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $22.00&#x7C;$25.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $22.00&#x7C;$25.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Huntsman. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Huntsman compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Huntsman's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Huntsman's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HUN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Huntsman analyst ratings.</a>
<h2>Delving into Huntsman's Background</h2>
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States &amp; Canada, Europe, Asia-Pacific, and the Rest of the world.
<h3>Unraveling the Financial Story of Huntsman</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3M period, Huntsman showcased positive performance, achieving a revenue growth rate of 3.49% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Huntsman's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -9.71%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Huntsman's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.64%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Huntsman's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.95%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.76, Huntsman adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 9 Analysts Discuss Huntsman Stock

Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) has outperformed the market over the past 5 years by 34.13% on an annualized basis producing an average annual return of 47.94%. Currently, Vertiv Holdings has a market capitalization of $27.49 billion. 
Buying $1000 In VRT: If an investor had bought $1000 of VRT stock 5 years ago, it would be worth $7,072.96 today based on a price of $72.20 for VRT at the time of writing.
<h3>Vertiv Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744754411_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Vertiv Holdings Stock In The Last 5 Years

Guidance

GAME

GameSquare Sees FY25 Revenue $100M-$105M Vs $121.4M Est

Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) has outperformed the market over the past 20 years by 11.46% on an annualized basis producing an average annual return of 19.45%. Currently, Quanta Services has a market capitalization of $40.48 billion. 
Buying $100 In PWR: If an investor had bought $100 of PWR stock 20 years ago, it would be worth $3,460.46 today based on a price of $273.03 for PWR at the time of writing.
<h3>Quanta Services's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744753512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Carrier Global

ニュース

最新ニュース Carrier Global (NYSE:CARR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル